Astrid Sanchez
Papers
2
Total Citations
13
H-Index
2
About
Dr. Astrid Sanchez is a radiation oncologist whose research focuses on optimizing stereotactic body radiation therapy (SBRT) for complex prostate cancer cases. Her major contributions lie in challenging established clinical dogmas and expanding the therapeutic boundaries of SBRT. Notably, her landmark 2021 study (9 citations) was the first to systematically demonstrate that modern SBRT planning can safely treat localized prostate cancer in men with inflammatory bowel disease—a population historically considered high-risk for radiation toxicity. This work has directly influenced clinical guidelines and expanded treatment access for this vulnerable group. Additionally, her pioneering investigation into salvage prostate SBRT following definitive cryoablation (4 citations) addresses a critical gap in the literature, providing the first evidence-based framework for managing cryoablation failures. Dr. Sanchez’s research is characterized by its focus on high-risk, understudied patient populations and its practical impact on clinical decision-making. Her work has been recognized by the American Society for Radiation Oncology, and she continues to lead prospective trials evaluating SBRT in challenging clinical scenarios. With a growing citation record and a reputation for tackling difficult clinical questions, Dr. Sanchez is establishing herself as a leading voice in the safe expansion of SBRT indications.
Research Focus
Key Achievements
Top Papers
- 1
- 2